Editorial
World J Hepatol
16(1):1-11.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.1
Abstract (716)
|
Core Tip (810)
|
Full Article (HTML) (2644)
|
Figures (1-1) (540)
|
Full Article (PDF)-1204K (226)
|
Full Article with Cover (PDF)-11949K (267)
|
Full Article (XML)-236K (151)
|
Audio-1342K (11)
|
Peer-Review Report-230K (161)
|
Answering Reviewers-97K (147)
|
Received: 10/26/2023
|
Revised: 12/04/2023
|
Accepted: 12/28/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (5)
|
Total Visits (8569)
|
Similar Articles (79)
|
Timeline of Article Publication (1)
|
Authors Evaluation (6)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Hepatol
16(1):12-16.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.12
Abstract (754)
|
Core Tip (801)
|
Full Article (HTML) (1912)
|
Tables (1-1) (613)
|
Full Article (PDF)-358K (189)
|
Full Article with Cover (PDF)-11106K (267)
|
Full Article (XML)-54K (135)
|
Audio-1072K (15)
|
Peer-Review Report-236K (125)
|
Answering Reviewers-62K (122)
|
Received: 11/09/2023
|
Revised: 12/05/2023
|
Accepted: 12/19/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (7063)
|
Similar Articles (21)
|
Timeline of Article Publication (1)
|
Authors Evaluation (8)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Minireviews
Role of fecal microbiota transplant in management of hepatic encephalopathy: Current trends and future directions
World J Hepatol
16(1):17-32.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.17
Abstract (868)
|
Core Tip (693)
|
Full Article (HTML) (7225)
|
Figures (1-2) (574)
|
Tables (1-5) (562)
|
Full Article (PDF)-1655K (314)
|
Full Article with Cover (PDF)-12399K (272)
|
Full Article (XML)-226K (158)
|
Audio-1259K (14)
|
Peer-Review Report-216K (144)
|
Answering Reviewers-145K (136)
|
Received: 09/16/2023
|
Revised: 12/02/2023
|
Accepted: 01/03/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (24)
|
Total Visits (12848)
|
Similar Articles (69)
|
Timeline of Article Publication (1)
|
Authors Evaluation (2)
|
Article Quality Tracking (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Hepatol
16(1):33-40.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.33
Abstract (836)
|
Core Tip (748)
|
Full Article (HTML) (4044)
|
Figures (1-1) (563)
|
Full Article (PDF)-601K (319)
|
Full Article with Cover (PDF)-11346K (199)
|
Full Article (XML)-89K (151)
|
Audio-384K (15)
|
Peer-Review Report-180K (130)
|
Answering Reviewers-74K (145)
|
Received: 10/10/2023
|
Revised: 11/06/2023
|
Accepted: 01/05/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (28)
|
Total Visits (9294)
|
Similar Articles (347)
|
Timeline of Article Publication (3)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Retrospective Cohort Study
Direct-acting antivirals failed to reduce the incidence of hepatocellular carcinoma occurrence in hepatitis C virus associated cirrhosis: A real-world study
World J Hepatol
16(1):41-53.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.41
Abstract (801)
|
Core Tip (715)
|
Article Highlights (737)
|
Full Article (HTML) (2723)
|
Figures (1-4) (507)
|
Tables (1-3) (510)
|
Full Article (PDF)-1672K (198)
|
Full Article with Cover (PDF)-12418K (188)
|
Full Article (XML)-173K (131)
|
Audio-467K (8)
|
Peer-Review Report-182K (120)
|
Answering Reviewers-71K (157)
|
Received: 11/21/2023
|
Revised: 12/18/2023
|
Accepted: 01/09/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (9412)
|
Similar Articles (2144)
|
Timeline of Article Publication (2)
|
Authors Evaluation (6)
|
Article Quality Tracking (0)
|
Reader Comments (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Observational Study
Metabolic puzzle: Exploring liver fibrosis differences in Asian metabolic-associated fatty liver disease subtypes
World J Hepatol
16(1):54-64.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.54
Abstract (769)
|
Core Tip (775)
|
Article Highlights (882)
|
Full Article (HTML) (2331)
|
Figures (1-3) (587)
|
Tables (1-2) (550)
|
Full Article (PDF)-1874K (211)
|
Full Article with Cover (PDF)-12619K (220)
|
Full Article (XML)-114K (154)
|
Audio-386K (20)
|
Peer-Review Report-233K (145)
|
Answering Reviewers-161K (138)
|
Received: 10/02/2023
|
Revised: 10/22/2023
|
Accepted: 12/18/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (11168)
|
Similar Articles (14)
|
Timeline of Article Publication (4)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
Reader Comments (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Basic Study
Subcellular distribution of prohibitin 1 in rat liver during liver regeneration and its cellular implication
World J Hepatol
16(1):65-74.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.65
Abstract (676)
|
Core Tip (647)
|
Article Highlights (719)
|
Full Article (HTML) (1685)
|
Figures (1-4) (492)
|
Full Article (PDF)-5746K (189)
|
Full Article with Cover (PDF)-16492K (186)
|
Full Article (XML)-96K (146)
|
Audio-3997K (13)
|
Peer-Review Report-192K (129)
|
Answering Reviewers-146K (136)
|
Received: 09/30/2023
|
Revised: 11/03/2023
|
Accepted: 11/28/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (7700)
|
Similar Articles (43)
|
Timeline of Article Publication (1)
|
Authors Evaluation (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Rifaximin on epigenetics and autophagy in animal model of hepatocellular carcinoma secondary to metabolic-dysfunction associated steatotic liver disease
World J Hepatol
16(1):75-90.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.75
Abstract (756)
|
Core Tip (729)
|
Article Highlights (796)
|
Full Article (HTML) (2874)
|
Figures (1-4) (485)
|
Tables (1-5) (513)
|
Full Article (PDF)-6006K (226)
|
Full Article with Cover (PDF)-16750K (220)
|
Full Article (XML)-200K (137)
|
Audio-376K (9)
|
Peer-Review Report-182K (140)
|
Answering Reviewers-60K (145)
|
Supplementary Material-355K (134)
|
Received: 11/03/2023
|
Revised: 12/11/2023
|
Accepted: 01/02/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (4)
|
Total Visits (11923)
|
Similar Articles (1989)
|
Timeline of Article Publication (3)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Meta-Analysis
Sorafenib plus transarterial chemoembolization vs sorafenib alone for patients with advanced hepatocellular carcinoma: A systematic review and meta-analysis
World J Hepatol
16(1):91-102.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.91
Abstract (679)
|
Core Tip (745)
|
Article Highlights (733)
|
Full Article (HTML) (2036)
|
Figures (1-4) (521)
|
Tables (1-4) (501)
|
Full Article (PDF)-5941K (199)
|
Full Article with Cover (PDF)-16687K (206)
|
Full Article (XML)-115K (144)
|
Audio-187K (10)
|
Peer-Review Report-215K (134)
|
Answering Reviewers-37K (152)
|
Received: 10/20/2023
|
Revised: 11/21/2023
|
Accepted: 12/12/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (4)
|
Total Visits (9318)
|
Similar Articles (2679)
|
Timeline of Article Publication (3)
|
Authors Evaluation (5)
|
Article Quality Tracking (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Case Report
World J Hepatol
16(1):103-108.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.103
Abstract (717)
|
Core Tip (740)
|
Full Article (HTML) (1828)
|
Figures (1-1) (564)
|
Full Article (PDF)-5068K (212)
|
Full Article with Cover (PDF)-15813K (188)
|
Full Article (XML)-63K (133)
|
Audio-811K (9)
|
Peer-Review Report-266K (143)
|
Answering Reviewers-225K (140)
|
Received: 08/25/2023
|
Revised: 10/24/2023
|
Accepted: 12/12/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (8097)
|
Similar Articles (4561)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Letter to the Editor
Review on article of effects of tenofovir alafenamide and entecavir in chronic hepatitis B virus patients
World J Hepatol
16(1):109-111.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.109
Abstract (719)
|
Core Tip (772)
|
Full Article (HTML) (1807)
|
Full Article (PDF)-325K (162)
|
Full Article with Cover (PDF)-11079K (199)
|
Full Article (XML)-24K (144)
|
Audio-243K (4)
|
Peer-Review Report-215K (110)
|
Answering Reviewers-19K (119)
|
Received: 10/30/2023
|
Revised: 12/04/2023
|
Accepted: 01/12/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (5823)
|
Similar Articles (405)
|
Timeline of Article Publication (5)
|
Authors Evaluation (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
